Slovak biotech company Axon Neuroscience creates antibodies to stop COVID-19 from reproducing

By bne IntelliNews November 24, 2020

Slovak clinical-stage biotech company Axon Neuroscience has created therapeutic antibodies able to prevent reproduction of the coronavirus (COVID-19), with the efficacy of these antibodies successfully tested in cooperation with the Virology Institute of Slovak Academy of Sciences' Bio-medical Centre, said Michael Matis from Axon Neuroscience to the Slovak News Agency on November 23.

The company has already reported positive pre-clinical results of its vaccine against COVID-19 in September, tested on mice with no adverse side effects. Now, it has launched the process of humanisation, which is a prerequisite for clinical tests.

"While developing a vaccine, we created antibodies that we used to map out the virus's weak spots. Some of them were seen to eliminate the virus completely, thereby showing their therapeutic potential. Their efficacy was proven in several conceptually distinctive tests developed at our facility," said Axon's science director Norbert Zilka, quoted by the news agency. 

“We'll focus on the humanisation process as part of the next step, and then we could launch the production process,” Zilka added.

Related Articles

How Ukrainian grain wrecked the Polish grain market

The Polish grain market has been thrown into disarray by cheap Ukrainian grain that sent prices plummeting in April, causing Warsaw to impose a five-month ban, backed up by the European Commission. ... more

Slovak OFZ aims to move part of production to Uzbekistan

Metallurgical company OFZ plans to transfer part of its production from Slovakia to Uzbekistan, The Slovak Spectator has reported. The ferroalloy production company from Oravsky Podzamok has ... more

EBRD 2023: EBRD, EU and ILX to co-operate to boost private-sector finance in Emerging Europe

The European Bank for Reconstruction and Development (EBRD), the European Union, and ILX Management, an emerging market asset manager, have joined forces to enhance private-sector finance in Emerging ... more

Dismiss